Vaxart, Inc. (VXRT) Stock Forecast
VXRT analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 2 analysts
- Price target
- $3.33 average of analyst targets
- Upside to target
- +594.4% from the latest close
- Next earnings
- —
- 52-week range
- $0.33 – $0.80
VXRT analyst ratings
2 analystsNumber of analysts at each rating.
VXRT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VXRT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.31 | −$0.31 | −$0.31 | −$0.04 | −675.0% | 1 |
| Current fiscal year (2026) | −$0.68 | −$0.68 | −$0.68 | $0.07 | −1,071.4% | 1 |
| Next fiscal year (2027) | −$1.03 | −$1.03 | −$1.03 | −$0.68 | −51.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VXRT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $27.2M | $27.2M | $27.2M | −62.4% | 1 |
| Current fiscal year (2026) | $118.6M | $118.6M | $118.6M | −50.0% | 1 |
| Next fiscal year (2027) | $2.4M | $0 | $4.7M | −98.0% | 2 |
VXRT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VXRT revenue: reported and forecast
VXRT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.31 | — | 0 up · 0 down |
| Current fiscal year (2026) | −$0.54 | −$0.54 | $0.06 | $0.06 | −$0.68 | +25.9% | 0 up · 1 down |
| Next fiscal year (2027) | −$0.67 | −$0.67 | −$0.68 | −$0.68 | −$1.03 | +53.7% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VXRT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VXRT beat in 11 of 12.
What analysts expect from VXRT
2 analysts cover Vaxart; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.33, 594.4% above the latest close of $0.48. Analysts expect earnings of −$0.68 per share for 2026, −1,071.4% from a year earlier. For 2027 the average estimate is −$1.03 per share on revenue of $2.4 million. Vaxart beat the EPS estimate in 11 of the last 12 quarters.
Related: VXRT income statement, VXRT key metrics, VXRT chart. See the VXRT stock overview for the latest quote and news.
VXRT forecast FAQ
What is Vaxart's price target?
The average analyst price target for Vaxart is $3.33, 594.4% above the latest close of $0.48.
Is Vaxart a buy, hold or sell?
Of 2 analysts covering Vaxart, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Vaxart's EPS forecast?
Analysts forecast −$0.68 per share for 2026 (range −$0.68 to −$0.68); for 2027 the estimate is −$1.03.
What is Vaxart's revenue forecast?
The average revenue estimate for 2026 is $118.6 million, growth of −50.0%; for 2027 it is $2.4 million.
Does Vaxart usually beat earnings estimates?
Vaxart reported EPS at or above the analyst estimate in 11 of the last 12 quarters.